A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

Clinical trial NCT03529773 · COMPLETED

Trial details

NCT number: NCT03529773
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Tract Infections

Start date: 2018-04-18
Primary completion: 2019-11-20
Enrollment: 1235

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.